Metformin is commonly used as first-line therapy unless contraindicated or poorly tolerated, but the addition of glucose-lowering therapies with different mechanisms of action is usually needed to provide adequate glycemic control [1,2,3], with the choice of agent being dependent on multiple factors, such as cost and the presence of comorbidities [1]
There is zero receptor overlap, meaning both compounds can work at full efficacy without interfering with each other
Additionally, the primary reporters of these ADEs were consumers, and social factors may contribute to females being more proactive in reporting adverse reactions ( The three most common SOCs identified in our study with tirzepatide were injury, poisoning and procedural complications, general disorders and administration site conditions, and gastrointestinal disorders
NAION is a rare medical condition that happens when theres not enough blood supplied to the optic nerve, which allows you to see
Provide patient education on self-management strategies, including medication adherence, lifestyle modifications, and regular self-monitoring of blood glucose levels